Hyperion DeFi, Inc. is a U.S. publicly listed company that is building a long-term strategic treasury of HYPE, the native token of the Hyperliquid blockchain. The company's primary objective is to provide shareholders with streamlined access to the Hyperliquid ecosystem. Shareholders gain compounding exposure to HYPE through the token's native staking yield and additional revenues from its on-chain utility. The company also continues the development of its proprietary Optejet User Filled Device for ophthalmic applications, reflecting its transformation from its prior focus on ophthalmic technology.
Hyperion DeFi Commences Share Buybacks, Retires All Legacy Debt, and Commits to Further Capital Optimization
Hyperion DeFi repurchased 240,124 HYPD shares at a weighted average gross price of $3.21 and retired approximately $8.6 million of legacy debt owed to Avenue Capital.
The debt paydown was partially funded by HYPE token sales, leaving the company with no long-term debt outstanding and $14.5 million in cash, cash equivalents, and stablecoins as of September 30, 2026.
With roughly 15.44 million shares outstanding, management says the debt-free balance sheet provides flexibility to scale its onchain DeFi businesses and further optimize the capital structure for stockholders.